Viatris (VTRS) EBITDA Margin Growth (3y) (2022 - 2026)
Powered by 
Analysis
Viatris (VTRS) EBITDA Margin Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.57 Bn | 38.91 Bn | 2.15 Bn | 1,129.00 |
| 2 | Viatris | 19.15 Bn | 18.27 Bn | 1.46 Bn | -925.00 |
| 3 | Dr Reddys Laboratories | 9.87 Bn | 9.70 Bn | 396.53 Mn | -2,128.00 |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.34 Bn | 334.51 Mn | 293.00 |
| 5 | Bausch Health Companies | 2.34 Bn | 498.25 Mn | 2.10 Bn | 693.00 |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | -230,408.00 |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 457.00 |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | -372.00 |
| 9 | Fennec Pharmaceuticals | 400.89 Mn | 359.65 Mn | 17.15 Mn | 15,005.00 |
| 10 | RedHill Biopharma | 178.33 Mn | 178.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -925.00 |
| Mar 31, 2026 | -1,299.00 |
| Dec 31, 2025 | -1.00 |
| Sep 30, 2025 | -898.00 |
| Jun 30, 2025 | -682.00 |
| Mar 31, 2025 | -10,544.00 |
| Dec 31, 2024 | -331.00 |
| Sep 30, 2024 | -186.00 |
| Jun 30, 2024 | -527.00 |
| Mar 31, 2024 | 1,157.00 |
| Dec 31, 2023 | 1,247.00 |
| Mar 31, 2023 | 367.00 |
| Dec 31, 2022 | -654.00 |